Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM-mediated Paget’s disease of bone

Owen Cronin, Laura Forsyth, Kirsteen Goodman, Stephanie Lewis, Catriona Keerie, Allan Walker , Mary Porteous, Roseanne Cetnarskyj, Lakshminarayan Ranganath, Peter Selby, Geeta Hampson, Rama Chandra, Shu Ho, Jon Tobias, Stuart Ralston

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBMJ Open
Issue number9
Early online date4 Sept 2019
Publication statusE-pub ahead of print - 4 Sept 2019

Cite this